Tyloxapol
 OpenBabel02212023462D

 10 10  0  0  0  0  0  0  0  0999 V2000
    0.0000    3.3000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    2.4750    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.7145    2.0625    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.7145    1.2375    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.4289    0.8250    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.4289   -0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.7145   -0.4125    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.7145   -1.2375    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.8250    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0  0  0  0
  2  3  1  0  0  0  0
  3  4  1  0  0  0  0
  4  5  2  0  0  0  0
  4 10  1  0  0  0  0
  5  6  1  0  0  0  0
  6  7  2  0  0  0  0
  7  8  1  0  0  0  0
  7  9  1  0  0  0  0
  9 10  2  0  0  0  0
M  END
>  <CdId>
256

>  <Mol Weight>
137.179

>  <Formula>
C8H11NO

>  <ID>
T0307

>  <Name>
Tyloxapol

>  <Synonyms>
Triton WR1339

>  <CAS>
25301-02-4

>  <Approved status>
FDA

>  <Disease>
Respiratory system

>  <Indication>
Bronchitis; Cystic Fibrosis

>  <Pathways>
NF-¦ªb; Others

>  <Target>
NF-¦ÊB inhibitor; Others

>  <Receptor>
NF-¦ÊB; LPL

$$$$
